Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant, neuromuscular disorder characterized by progressive weakness of muscles in the face, shoulder and upper arm. Deletion of integral copies of a 3.3 kb repeated unit from the subtelomeric region on chromosome 4q35 has been shown to be associated with FSHD. These repeated units which are apparently not transcribed, map very close to the 4q telomere and belong to a 3.3 kb repeat family dispersed over heterochromatic regions of the genome. Hence, position effect variegation (PEV), inducing allele-specific transcriptional repression of a gene located more centromeric, has been postulated as the underlying genetic mechanism of FSHD. This hypothesis has directed the search for the FSHD gene to the region centromeric to the repeated units. A CpG island was identified and found to be associated with the 5' untranslated region of a novel human gene, FRG1 (FSHD Region Gene 1). This evolutionary conserved gene is located about 100 kb proximal to the repeated units and belongs to a multigene family with FRG1 related sequences on multiple chromosomes. The mature chromosome 4 FRG1 transcript is 1042 bp in length and contains nine exons which encode a putative protein of 258 amino acid residues. Transcription of FRG1 was detected in several human tissues including placenta, lymphocytes, brain and muscle. To investigate a possible PEV mechanism, allele-specific FRG1 steady-state transcript levels were determined using RNA-based single-strand conformation polymorphism (SSCP) analysis. A polymorphic fragment contained within the first exon of FRG1 was amplified from reverse transcribed RNA from lymphocytes and muscle biopsies of patients and controls. No evidence for PEV mediated repression of allelic transcription was obtained in these tissues. However, detection of PEV in FSHD patients may require analysis of more specific cell types at particular developmental stages.
INTRODUCTION
Facioscapulohumeral muscular dystrophy (FSHD) is a clinically heterogeneous, autosomal dominant myopathy with an estimated prevalence of 1 in 20 000 (1, 2) . Initially, the facial and shoulder-girdle muscles are affected but during progression of the disease the upper-arm, abdominal, pelvic-girdle and foot-extensor muscles can also become involved (1, 3) .
The FSHD locus has been assigned to the distal long arm of chromosome 4 (4q35) by linkage analysis (4, 5) , with a most likely location distal to D4S139 (6) (7) (8) . More recently, rearrange ments within a polymorphic EcoRI fragment were detected in *To whom correspondence should be addressed +Present address: Department of Human Genetics, Roswell Park Cancer Institute, Buffalo, NY, USA ^Present address: Life Sciences Division LS-3, Los Alamos National Laboratory, Los Alamos, NM, USA FSHD patients using probe pl3E -ll (D4F104S1) (9) . These rearrangements were found to be due to deletion of an integral number of 3.3 kb tandemly repeated units (D4Z4) (9, 10) . Although these 3.3 kb repeated units contain a double homeobox motif ( 11, 12) , no transcripts derived from this locus could be identified (11) (12) (13) (14) . In addition, fluorescence in situ hybridization (FISH) experiments showed that the tandem array of 3.3 kb repeats maps very close to the 4q telomere (13, 15, 16) , suggesting a probable location of the FSHD gene proximal to the repeated units. Recent data suggested that the repeated units are members of a 3.3 kb repeat family dispersed over heterochromatic regions of the genome (14) . This is supported by FISH results demonstrating hybridization of the 3.3 kb repeated unit to the short arms of all acrocentric chromosomes as well as to chromosomes i q 12, 4q35,10qter,and lOcen (13, 16) . Weak signals were also detected on a large heterochromatic region on chromosome 9ql2, and chromosome Y. Therefore, considering that the 3.3 kb repeated unit may be heterochromatin-associated, deletion of a number of these repeated units may lead to position effect variegation (PEV) by alteration of the chromosomal structure. Heterochromatinization or extensive chromatin packaging (17) can transcriptionally silence a gene by (i) inducing a later replication time point which will put the gene at a disadvantage in the competition for transcription factors (18) , or (ii) generating a more tightly condensed structure of the chromatin which itself contributes to its transcriptionally silent state (18) (19) (20) . A classic example of heterochromatinization in mammals involves transcriptional silencing of genes by X chromosome inactivation (21) (22) (23) , Furthermore, since telomeres have a functional location in the nucleus (24) , the FSHD associated deletions may also have implications for the nuclear organization. PEV leading to reduced transcript levels of one allele of a gene has been observed in Drosophila, yeast and mammals (17, 25) , and may affect genes over a region of several hundred kb (26) . When taken into account that the deletion prone EcoRl fragments can be 300 kb in healthy individuals and 10 kb in FSHD patients (27) , the FSHD-associated deletions of 3.3 kb repeated units may also involve several hundred kb. Therefore, the FSHD candidate gene region sub jected to several gene identification methods was chosen to extend about 150 kb proximal to the 3.3 kb repeats.
Here, we report the isolation and characterization of a novel gene cloned from the FSHD region (F R G I). The PEV hypothesis was tested by analysis of allele-specific transcription of this gene in lymphocytes and muscle tissue of patients and controls.
RESULTS

Isolation and sequence analysis of FRG1 cDNAs
Previous mapping studies (28, 29) showed the presence of a CpG island located within a 6.5 kb EcoRl fragment of cosmid cT171 which was isolated from a cosmid library made from YAC 25C2E (D4S1093) (28) . A total of 6.2 kb of contiguous sequence from this 6.5 kb EcoRl fragment was determined (GenBank accession number L76174) by sequencing adjacent Pstl subclones located within this fragment. The CpG island spans a region of 1 kb showing a G+C content of 63% and a CpG:GpC ratio of 0.8. A 1.2 kb Pstl subclone (plOB) encompassing the CpG island ( Fig. 1) , was used as a probe to screen a human skeletal muscle cDNA library. A 640 bp cDNA clone (10B7, Fig. 1 ), was isolated and, after sequencing, shown to contain the 3' end of a cDNA. Clone 10B7 hybridized to a LI kb transcript in total RNA from lymphocytes and fetal muscle, and poly-(A)+ RNA from adult muscle, fetal brain and placenta (Fig. 2) . Subsequently, two cDNA clones were obtained by screening a total infant brain cDNA library (BS3; 3.5 kb insert), and a fetal brain cDNA library ( 10B 1; 1.3 kb insert), with probe 10B7 (Fig. 1) . These clones were sequenced and their unexpectedly large cDNA inserts were shown to be due to splicing aberrations and cloning artefacts (see below). Additional cDNA fragments were obtained by amplification of different cDNA libraries using one of the cDNA library vector-spe cific primers flanking the cloning site, in combination with 10B7-based primers. Two cDNA fragments, PLC2FB22 (700 bp) and ML8RT3 (780 bp) were amplified from the placenta and muscle cDNA library, respectively. By sequence analysis these fragments were found to overlap, spanning 913 bp (Fig. 1) . To determine the transcription start site of the cDNA, two primers at the 5' end of the cDNA (lr* and 2r) were designed to perform 5' RACE [rapid amplification of cDNA ends (30) ] from human brain cDNA. The obtained RACE products were sequenced and found to start at, or just distal of, position -191 upstream from the putative transiation initiation site (Fig. 3b) . Subsequently, primers (If and 9r) were chosen at positions -134 and 801 to perform RT-PCR on RNA isolated from a chromosome 4 only cell hybrid, muscle tissue, and lymphocytes. In all cases, an identical 935 bp product was obtained which is in accordance widi the total transcript length of about 1.1 kb detected by Northern blot analysis. Further sequence analysis confirmed the identity of these RT-PCR products. The complete cDNA sequence of tliis novel human gene, named FRG1 (FSHD Region Gene 1), was compiled (GenBank accession number L76159); spanning 1042 bp and containing an open reading frame of 258 amino acid residues (Fig. 3b) . The putative translation start site is the first in frame ATG codon located 191 bp downstream of the 5' end of the transcript, which conforms to the Kozak consensus sequence (31) . The 3' untranslated region is 74 bp and ends with a poly-(A) tail 25 bp downstream of a polyadenylation signal at position 821 (Fig. 3b) . Nucleotide sequence database searches (BLAST-N) identified several highly homologous human EST clones: a human HL60 EST clone (accession number D 19665), and from the WashU-Merck EST Project; accession numbers T41211, T51111, T51019; all being 96-99% homologous to the 3' end of the cDNA, and R77057; 95% homologous to the internal part of the cDNA, Furthermore, a mouse EST clone (GEG-123, accession number X71639) showed high homology (86%) to the 3' end of the FRGI transcript. Southern blot analysis also indicated that FRGI is evolutionarily conserved (Fig. 4a) . No significant homology to known genes was detected in either the nucleotide sequence databases or the protein databases (BLAST-P). Protein motif searches gave no indication of a possible function for the deduced FRGI protein.
Genomic organization of F R G I
Southern blot analysis revealed that the FRGI cDNA is distributed over three EcoRl fragments contained within cosmid cTI71 ( Fig. 1, Fig. 4b ). These EcoRl fragments were subcloned and partially sequenced using FRGI cDNA-based primers. The 1042 bp cDNA sequence was found to be completely identical to the genomic sequence and is composed of nine exons (Fig. 1) . The sequences of the intron-exon boundaries were determined and shown to be in accordance with splice site consensus sequences ( Table 1) .
The promoter region of FRGI (Fig. 3a , GenBank accession number L76173) coincides with the identified CpG island (see above). No TATA or CAAT box motifs were found, but three putative Spl binding sites (32) are present at positions -743, -403, and -310, which may function as control elements of transcription (33) . Absence of a TATA box in genes with a 5' CpG island has been reported for many housekeeping genes and appears to be related to the regulation of widely expressed genes (34) .
Chromosomal distribution of F R G I
The 935 intensities (Fig. 4) . Only three of these fragments are derived from the chromosome 4q35 region (Fig. 1, Fig. 4b ), suggesting the presence of multiple FRG l -related sequences in the genome. To identify the chromosomal origin of the different members of this novel multigene family, the three EcoRl fragments of cosmid cT171 containing the FRG l exons were independently used as probes for fluorescent in s i t u hybridization (FISH) to metaphase spreads. For each fragment an identical hybridization pattern was detected. Hybridization signals were found at chromosome 4q35, at three sites in the pericentromeric region of chromosome 9, at the short arm of all acrocentric chromosomes (13, 14, 15, 21, and 22) and at the centromeric region of chromosome 20 (Fig. 5) . Subsequent PCR analyses of DNA from a monochromosomal somatic cell hybrid mapping panel using several primer combina tions, confirmed the chromosomal dispersion of F/?G/-related sequences. With most primer combinations, appropriate PCR products could be amplified from ceil hybrids containing one of the human chromosomes 4, 8, 9, 12, 13, 14, 15, 20, 21, and 22. To illustrate this, amplification of a fragment containing part of intron 4 and exon 5 using primers 5 fl and 5r, is shown in Figure  6a . The appropriate 320 bp product was detected in somatic cell hybrids containing chromosomes 4, (Fig. 6b) . In addition, RT-PCR analysis of total RNA isolated from somatic cell hybrids specific -769 a g c g c t g c a c g g c t c c c t c c a c g c c t c c g r c c c t g 1 1 1 c c t c c a t c a g a. c a g g a c t a g c t 1   t c c a t c t c t g t c g g g c a a a t g c t g c c c a g c c t t c a a g a c c c t c c t c a g a t g c a c g c c t   6 4 9 c c a c g a t t a g g c c t t c t t t c a g a c c c c t g c c c t g t a a c a c g g g c t a c c a t a a c t c t c c a c   58 9 c c t c a g c e c c a c a t t c c c a c a g c a c t c g c g a c g t c c g c g a c c c t c   5 2 9 t t c t c t t t t a g g g t a t t t c c t g c t t c t t t c c t g c a c a c c a g c t t a c c a c a c c g c a g g c c a g c g a g g g c a g c c   4 0 9 c g c t t c c c s r c c c c c g c g a g g a c c g t c g c c a g c c c g c t g c t c t a g c a g g a g g c g g t t c c a c   34 9 a g c g c a c c c g g c a g c c c a g c c a c c g t c a g c a c c g g c c t c g g g r c g g g c 1 1 1 1 1 c c 1 1 c c g g   2 3 9 g a g g c g c g a a t c c t c a g a g g g c t c c t t g a g a g g g c g c c a g g g a g c a c g t g c g c g c g g a t g   -229 a c c t t t t g g c c c t c t g c g g c c g c c g t a g c t c c c c g g c a 
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Fluorescent in situ hybridization
Metaphase chromosome spreads from normal human lympho cytes were hybridized with the 3 kb, 6.5 kb, and 9.5 kb EcoRl fragments of cosmid cT171. Probes were labelled by nick translation with biotin 11-dUTP (Sigma) (50) . Hybridization, washing and staining were performed as previously described (8) .
RNA isolation and Northern blot analysis
Total RNA was isolated from various human tissues and somatic cell hybrids as previously described by Chomczynski and Sacchi (49) . Poly-(A)+ RNA was isolated using the PolyATtract mRNA Isolation Systems kit (Promega) or purchased from ClonTech. Northern blots were prepared containing 20 (tg total RNA or 1 jig poly-(A)+ RNA. Hybridizations were performed in a formamide hybridization mix (45) for 16 h at 54°C using a -32P labelled 10B7 as probe. The blots were washed at 65 °C and to a stringency of 2x SSC/0.1% SDS, followed by autoradiography for 16-36 h at -7 0°C using Konica AX film with an intensifying screen.
(RT-) PCR analysis cDNA was synthesized from 5 (ig of total RNA isolated from human muscle, human lymphocytes, somatic cell hybrids specific for the particular chromosomes, Chinese hamster lung cells (V79) and mouse A9 cells, using an oligo-dT primer and the AMV Reverse Transcriptase kit from Promega. The primers used for (RT-) PCR analyses are indicated in Figure 1 and Table 1 . All primers were provided by Isogen Bioscience BY, Maarssen, The
Allele-specific analysis of FRG I steady-state transcript levels (RNA-based SSCP)
cDNA of lymphocytes and muscle tissue was primarily amplified using primers If and 9r (Fig. 1, Table 1 ). For the SSCP analysis (35, 36) , PCR products were diluted 1:50 of which subsequently 1 jal was used for secondary amplifications with primer combina tions lf/lr51, lf/2r, 2f/6r or 5f/9r (Fig. 1 , Table 1 ) and with incorporation of oc-32P labelled dCTP Products were diluted 1:25 in a formamide loading buffer (1:1 mix of 95% formamide/20 mM EDTA and 0.1% SDS/ 10 mM EDTA) and denatured at 100° C for 10 min. Electrophoresis was performed in non-denaturing 0.5x MDE polyacrylamide gels (J.T. Baker) and 0 .6x TBE buffer (lx: 0.09 M Tris, 0.09 M Boric acid, 0.002 M EDTA, adjusted to pH 8.0) using a BRL-S2 vertical gel apparatus (Life Technologies, Inc.). Gels of 40 cm were run at 25 Watt for 3-4 h and subsequently dried at 80° C under vacuum, and exposed at -70 °C for 12-24 h to Konica AX film with an intensifying screen.
